Literature DB >> 12489109

Expression, localization, and activity of glycogen synthase kinase 3beta during mouse skin tumorigenesis.

Hugo Leis1, Carmen Segrelles, Sergio Ruiz, Mirentxu Santos, Jesús M Paramio.   

Abstract

Glycogen synthase kinase 3 (GSK-3) is a protein kinase that plays essential roles in the control of several developmental, metabolic, and apoptotic processes. Owing to its negative actions on several oncogenic insults, it has been considered a putative functional tumor suppressor. We studied the expression, activity, and localization of GSK-3beta during the process of chemically induced two-stage mouse skin carcinogenesis and also in the tumors generated upon subcutaneous injection of Akt-transformed keratinocytes. We found that GSK-3 activity was downregulated at the later stages of promotion by tyrosine 216 dephosphorylation and serine 9 phosphorylation. The data obtained with Akt-transformed keratinocytes clearly suggested the involvement of Akt in serine 9 phosphorylation of GSK-3beta. Finally, besides functional inactivation, significant basal activity of GSK-3beta was detected in all cases, indicating that this enzyme provides essential functions to malignant keratinocytes. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12489109     DOI: 10.1002/mc.10087

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  22 in total

Review 1.  Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.

Authors:  Richard S Jope; Christopher J Yuskaitis; Eléonore Beurel
Journal:  Neurochem Res       Date:  2006-08-30       Impact factor: 3.996

2.  Delayed administration of a single dose of lithium promotes recovery from AKI.

Authors:  Hui Bao; Yan Ge; Zhen Wang; Shougang Zhuang; Lance Dworkin; Ai Peng; Rujun Gong
Journal:  J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 10.121

Review 3.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

4.  Resveratrol plays dual roles in pancreatic cancer cells.

Authors:  Lei Yang; Liang Yang; Wencong Tian; Jing Li; Jie Liu; Mengmeng Zhu; Yan Zhang; Yinan Yang; Fei Liu; Qiong Zhang; Qianqian Liu; Yanna Shen; Zhi Qi
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-07       Impact factor: 4.553

5.  GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug.

Authors:  S-H Kao; W-L Wang; C-Y Chen; Y-L Chang; Y-Y Wu; Y-T Wang; S-P Wang; A I Nesvizhskii; Y-J Chen; T-M Hong; P-C Yang
Journal:  Oncogene       Date:  2013-07-15       Impact factor: 9.867

Review 6.  GSK-3: a multifaceted player in acute leukemias.

Authors:  Alberto M Martelli; Camilla Evangelisti; Francesca Paganelli; Francesca Chiarini; James A McCubrey
Journal:  Leukemia       Date:  2021-04-02       Impact factor: 11.528

7.  Transgenic mice expressing constitutively active Akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma.

Authors:  Marta Moral; Carmen Segrelles; Ana Belén Martínez-Cruz; Corina Lorz; Mirentxu Santos; Ramón García-Escudero; Jerry Lu; Agueda Buitrago; Clotilde Costa; Cristina Saiz; José M Ariza; Marta Dueñas; Jose L Rodriguez-Peralto; Francisco J Martinez-Tello; Maria Rodriguez-Pinilla; Montserrat Sanchez-Cespedes; John Digiovanni; Jesús M Paramio
Journal:  In Vivo       Date:  2009 Sep-Oct       Impact factor: 2.155

Review 8.  Glycogen synthase kinase 3 beta: can it be a target for oral cancer.

Authors:  Rajakishore Mishra
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

Review 9.  Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.

Authors:  Jia Luo
Journal:  Cancer Lett       Date:  2008-07-07       Impact factor: 8.679

10.  The inactive form of glycogen synthase kinase-3β is associated with the development of carcinomas in galectin-3 wild-type mice, but not in galectin-3-deficient mice.

Authors:  Daniella Fernandes Mendonça; Roger Chammas; Fu-Tong Liu; Suely Nonogaki; Sergio Vitorino Cardoso; Adriano Mota Loyola; Paulo Rogério de Faria
Journal:  Int J Clin Exp Pathol       Date:  2012-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.